• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Fusion Pharmaceuticals Acquires IPN-1087

    Strata Oncology Unveils Strata PATH Trial

    Alimentiv Acquires McDougall Scientific

    Q BioMed Inks Strontium89 Supply Pact

    PCI Pharma Services Appoints SVP, CFO
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WuXi AppTec Completes OXGENE Acquisition

    Celonic Group Announces Plans for New Facility in Switzerland

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production

    Arcline Investment Acquires ChargePoint Technology
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reshaping the Pharmaceutical Supply Chain

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Strata Oncology Unveils Strata PATH Trial

    Alimentiv Acquires McDougall Scientific

    WuXi AppTec Completes OXGENE Acquisition

    Live Webinar - Formulation Strategies for Poorly Soluble Molecules

    Celonic Group Announces Plans for New Facility in Switzerland
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Baxter BioPharma Solutions

    Syngene

    Aphena Pharma Solutions

    Adare Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    Emergent BioSolutions

    PCI Pharma Services

    Syngene

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Pharma Beat

    Anyone Fancy a Beer?

    The centuries-old brew continues to be investigated for its medicinal properties

    Anyone Fancy a Beer?
    Anyone Fancy a Beer?
    Related CONTENT
    • Embion, Asahi Group Enter Strategic Collaboration
    • Life Science Success Podcast: Matt Hicks
    • CPhI North America Event Info
    • Tackling TB Resistance
    • Could Nuts Ward Off Cancer?
    Adele Graham-King, Contributing Editor05.05.16
    While many of us indulge in a ‘medicinal’ beer or two regularly, it may come as a surprise to learn that beer has actually been either used or investigated for its medicinal properties for centuries. And boy! It sure can make you feel better, but of course that doesn’t prove a thing.

    As long as 2,000 years ago ancient Nubians—a kingdom which would now be in what is the Sudan—made beer that is thought to have antibiotic properties. Investigations in the 1980s by George Armelagos, an anthropologist from Emory University in Atlanta, recovered human remains that seemed to have high concentrations of tetracycline in them, even though it hadn’t been discovered. The reason for this is thought to be related to beer. The Nubians brewed beer in vats, a prime stomping ground for the soil-based bacteria named Streptomyces, which is responsible for making tetracycline. The Nubian mechanisms for making beer differed from those used today due to the fact that they made it from bread. The wheat grains for the bread were germinated before being made into flour and then made into dough, which was partially cooked, leaving the center raw. The bread was placed into a concoction of unmilled grains and left to ferment to create their beer. I suspect it didn’t quite taste like a bottle of Bud but they do seem to have harnessed the antibiotic properties of the brew.

    Hops didn’t enter into the brewing process until the 15th Century in England, but they are the flowers of the hop plant, which assists in preservation and taste of the tipple. They have extensive anti-bacterial properties and help create a balanced taste between the sweetness of the malt and the bitterness that they inherently carry. They have also been used historically in herbal medicine for anxiety and insomnia due to the alpha acid 2-methyl-3-buten-2-ol, which results from the breakdown of alpha acids. Historically used as an anesthetic, it is thought that this could be responsible for the calming effects that they could create.

    From an alcohol point of view there are two distinct schools of thought as to the medicinal impact. Low to moderate alcohol consumption is thought to confer benefits on the cardiovascular system due to the effect they have on high density lipoproteins (HDLs), cellular signaling, platelet function in clot formation, and clot dissolution. And indeed there have also been claims that it can extend life-span, improve libido, protect against the common cold, reduce the chance of developing dementia, reduce the risk of gallstones, and decrease the odds of developing Type II diabetes. The only thing is that these claims are all related to alcohol and not beer or hops.

    So what’s the score with beer? Because beer is made from hops it differs from other alcoholic beverages—wine is thought to have different medicinal properties due to the anti-oxidants found in the grapes—and it is the chemical properties that are found in the make-up of the hops which have become of increasing interest in developing pharmaceuticals. Although the rumblings have been going on literally for centuries, harnessing the capabilities of these little treasures is the difficult part.

    In 2009 a study published in Molecular Nutrition and Food Research demonstrated that hop bitter acids (HBA) had anti-inflammatory effect on fibroblasts, which play an important part in the anti-inflammatory pathway. In 2006, research presented in the Journal Maturitas illustrated that the hop extract 8-prenylnaringenin (8-PN) had a positive impact on menopausal symptoms. And in 2008 evidence presented in Phytotherapy Research suggested that xanthohumol extracted from hops (Humulus lupulus L.) inhibited growth in hepatocellular carcinoma cell lines. These are just a few of the studies. The chemical components of hops have also been suggested to be effective in managing infection, HIV, acne, weight loss, CV diseases, and liver disease.

    But the most recent hop research is probably some of the most promising in recent years. Extracting the active chemical candidate ingredients and being able to successfully and repeatedly replicate them would mean that there would no longer be the need to extract them from the plants. Kristopher Waynant, who is based in the Department of Chemistry at the University of Idaho, and his team are working on creating humulones, the alpha acids that have anti-cancer and anti-inflammatory effects found in hops, as well as lupulones, which are beta acids that demonstrate similar beneficial qualities.

    Presenting their work at the 2016 National Meeting & Exposition of the American Chemical Society in San Diego, Waynant outlined their progress in creating a library of analytical standards for the two compounds. In order to be able to synthesize pharmaceutical agents researchers need to be able to compare them to standards that currently do not exist. Even if researchers manage to extract what they think are the pharmacologically active compounds they currently have no way of verifying that they have the right one. If it is possible to make them artificially then it is possible to easily recognize them. The researchers are in the process of creating synthetic humulones and lupulones in the laboratory.

    Phloroglucinol was their starting point, and through various chemical reactions they’re currently in a situation where they have synthesized three different humulones. However, as successful as this has been, the initial pathways that were investigated have not been the most efficient; therefore they are still ‘tweaking’ the step-by-step processes in order to have the most streamlined approach to creating the compounds.

    Once this process is perfected the possibilities for investigating the pharmacological activities of these drug candidates will open up massively and is incredibly exciting for development scientists. The plans for the laboratory are to work to extend the range of humulones and lupulones that they are able to synthesize, and work closely with the creative minds in drug development to develop compounds that are able to treat cancers and inflammatory disease. Going forward the horizon is looking incredibly promising. The small hop may certainly come into its own and potentially create a giant leap in the therapeutic use of the little gem. Here’s one thing to keep in mind. Next time you order your beer, get an IPA (Indian Pale Ale). This is the ‘hoppiest’ of the beers and may turn out to be a true medicinal fixer.


    Adele Graham-King
    Contributing Editor

    Adele is a design consultant who works in product development for medical and healthcare applications. Her background is in pharma, and she has a degree in applied physiology.
    Related Searches
    • cancer
    • Development
    • Pharma
    • study
    Suggested For You
    Embion, Asahi Group Enter Strategic Collaboration Embion, Asahi Group Enter Strategic Collaboration
    Life Science Success Podcast: Matt Hicks Life Science Success Podcast: Matt Hicks
    CPhI North America Event Info CPhI North America Event Info
    Tackling TB Resistance Tackling TB Resistance
    Could Nuts Ward Off Cancer? Could Nuts Ward Off Cancer?
    CPhI North America Debuts in Philadelphia May 16 - 18 CPhI North America Debuts in Philadelphia May 16 - 18
    The Trials and Tribulations  of Male Contraception The Trials and Tribulations of Male Contraception
    ‘Smart’ Heparin Delivery Could Self-Modulate ‘Smart’ Heparin Delivery Could Self-Modulate
    Is Nicotine Such a ‘Bad Boy’? Is Nicotine Such a ‘Bad Boy’?
    Rho to Recruit New Team Members During ACRP 2016 Rho to Recruit New Team Members During ACRP 2016
    Developing Palatable Drug Products Developing Palatable Drug Products
    BMS, Princeton in Molecular Synthesis Alliance BMS, Princeton in Molecular Synthesis Alliance
    The Un-Networking Trend and Your Job Search The Un-Networking Trend and Your Job Search
    Conatus Pharma Names Mason Yamashita VP, Pharmacovigilance Conatus Pharma Names Mason Yamashita VP, Pharmacovigilance
    A Toast to Water Savings at UK Brewery A Toast to Water Savings at UK Brewery

    Related Pharma Beat

    • Drug Development

      NSAIDs – Friend or Foe?

      Although widely used for years, NSAIDs have side effects that could eventually change their OTC status
      Adele Graham-King, Contributing Editor 06.06.17

    • Drug Development | Drug Discovery
      Tackling TB Resistance

      Tackling TB Resistance

      The TB Alliance is partnering with universities, government agencies, public agencies and a small number of pharma compani
      Adele Graham-King, Contributing Editor 05.09.17

    • Drug Development

      Could Nuts Ward Off Cancer?

      Recent research looks into the anti-cancer properties of various nuts
      Adele Graham-King, Contributing Editor 04.03.17


    • Drug Delivery | Drug Development | R&D

      ‘Smart’ Heparin Delivery Could Self-Modulate

      A group of researchers have spent the past two years investigating self-controlling dosing and monitoring systems
      Adele Graham-King, Contributing Editor 01.26.17

    • Drug Development | Drug Discovery | R&D

      Is Nicotine Such a ‘Bad Boy’?

      Investigating this controversial compound’s potential health benefits
      Adele Graham-King, Contributing Editor 11.09.16

    • Drug Development | Drug Discovery | R&D

      Blackberry Wine: Could it Help Your Diabetes?

      Recent research points towards the positive impact ‘berry wine’ might have on diabetes
      Adele Graham-King, Contributing Editor 10.11.16


    • Drug Development

      Chipping Away at the Old Cancer Block

      Advances in cancer treatment continue to march towards finding a cure
      Adele Graham-King, Contributing Editor 04.05.16

    • Clinical Trials | Drug Development

      The 3D Printed Pill

      It’s the future…or is it?
      Adele Graham-King, Contributing Editor 01.28.16

    • Clinical Trials | Drug Development | Drug Discovery | R&D

      Are We There Yet?

      Many promising cancer treatments are on the horizon
      Adele Graham-King, Contributing Editor 07.14.15


    • APIs | Bioassay Development | Drug Development | Methods Development | Process Development | Toxicology

      The Last Chance Saloon?

      Looking at the pharmaceutical ‘diet’ of anti-obesity drugs
      Adele Graham-King, Contributing Editor 06.02.15

    • Clinical Trials | Drug Development

      100 New Drugs in 10 Years?

      Repurposing drug candidates that never saw the light of day
      Adele Graham-King, Contributing Editor 03.06.15

    • APIs | Bioassay Development | Clinical Trials | Drug Development | Drug Discovery | Methods Development | Process Development | R&D | Toxicology

      Experimental Drugs

      To use or not to use unlicensed drugs? That is the question.
      Adele Graham-King, Contributing Editor 01.29.15


    • Drug Delivery | Drug Development
      The End of a Century

      The End of a Century

      Looking at 15 years of pharmaceutical evolution.
      Adele Graham-King 10.14.14

    • Chemistry | Drug Discovery | Supply Chain

      Toward a Process-Centered Pharma

      Saying “No” to change is normal, but adopting true QbD practices could save the industry about 20-25% of its global revenue and allow pharma to add two to three billion patients to its customer base
      Girish Malhotra, EPCOT International 06.03.14

    • Bioassay Development | Drug Development | Methods Development | Process Development | Toxicology

      A Questionable Combination

      ...
      Ed Silverman, Contributing Editor 06.05.13

    Trending
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • AbbVie Opts To Acquire Mitokinin
    • Bormioli Opens New Glass Research Center
    • Arcline Investment Acquires ChargePoint Technology
    • WuXi AppTec Completes OXGENE Acquisition
    Breaking News
    • Fusion Pharmaceuticals Acquires IPN-1087
    • Strata Oncology Unveils Strata PATH Trial
    • Alimentiv Acquires McDougall Scientific
    • Q BioMed Inks Strontium89 Supply Pact
    • PCI Pharma Services Appoints SVP, CFO
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Low Levels of Vitamin D and Calcium Linked to COVID-19 Severity
    Probiotic Evidenced to Assist Digestive Recovery from a Complex Surgery
    AHPA Submits Comments to FDA on Proposed Traceability Rule
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    AOC Announces EMEA Price Increase
    Mule-Hide Products Co. Introduces Seal-Fast Liqui-Flash
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    NAMSA Acquires American Preclinical Services
    Quidel's QuickVue At-Home COVID-19 Test Earns EUA
    Memic Receives FDA Marketing Authorization for Hominis
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Fusion Pharmaceuticals Acquires IPN-1087
    Strata Oncology Unveils Strata PATH Trial
    Alimentiv Acquires McDougall Scientific
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    IT Cosmetics Supports Women’s Confidence
    Inter Parfums Reports a Strong Fourth Quarter
    Universal Engraving Announces New President
    Happi

    Latest Breaking News From Happi

    Croda International Acquires Alban Muller
    Givaudan Active Beauty Launches Omegablue
    Sozio Acquires Scentessence
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Abbott Label installs Domino K600i dual bar digital UV inkjet printer
    Crossmark turns to Eagle Systems for cold foil
    Maxcess launches Tidland PressureMax Airshaft Pressure Monitoring System
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Domtar Completes Sale of Personal Care Business
    Mitsui to Sell Chinese Nonwovens Business
    Dr. J's Disinfectant Wipes Approved for Distribution in CA
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Approves Accufix Surgical's Accu-Joint Hemi Implant
    FDA OKs Q-Collar Device to Protect Athletes’ Brains During Head Impacts
    SeaSpine Releases Reef TO (TLIF Oblique) Interbody System
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login